Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
490.64
-6.95 (-1.40%)
At close: Sep 12, 2025, 4:00 PM EDT
489.47
-1.17 (-0.24%)
After-hours: Sep 12, 2025, 5:23 PM EDT
Medpace Holdings Stock Forecast
Stock Price Forecast
The 10 analysts that cover Medpace Holdings stock have a consensus rating of "Hold" and an average price target of $424.1, which forecasts a -13.56% decrease in the stock price over the next year. The lowest target is $305 and the highest is $510.
Price Target: $424.1 (-13.56%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medpace Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 8 | 8 | 9 | 7 | 7 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 2 | 2 | 2 |
Total | 10 | 10 | 11 | 10 | 10 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Hold Maintains $400 → $450 | Hold | Maintains | $400 → $450 | -8.28% | Sep 9, 2025 |
Rothschild & Co | Rothschild & Co | Strong Buy → Hold Downgrades $342 → $474 | Strong Buy → Hold | Downgrades | $342 → $474 | -3.39% | Sep 3, 2025 |
UBS | UBS | Hold → Strong Sell Downgrades $300 → $305 | Hold → Strong Sell | Downgrades | $300 → $305 | -37.84% | Jul 29, 2025 |
Mizuho | Mizuho | Buy Maintains $328 → $510 | Buy | Maintains | $328 → $510 | +3.95% | Jul 25, 2025 |
Truist Securities | Truist Securities | Hold Maintains $298 → $436 | Hold | Maintains | $298 → $436 | -11.14% | Jul 23, 2025 |
Financial Forecast
Revenue This Year
2.51B
from 2.11B
Increased by 19.01%
Revenue Next Year
2.73B
from 2.51B
Increased by 8.88%
EPS This Year
14.33
from 12.63
Increased by 13.45%
EPS Next Year
15.75
from 14.33
Increased by 9.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.6B | 3.1B | |||
Avg | 2.5B | 2.7B | |||
Low | 2.4B | 2.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 25.4% | 22.9% | |||
Avg | 19.0% | 8.9% | |||
Low | 12.5% | -1.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 15.28 | 18.11 | |||
Avg | 14.33 | 15.75 | |||
Low | 13.54 | 14.27 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.0% | 26.4% | |||
Avg | 13.5% | 9.9% | |||
Low | 7.2% | -0.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.